News Digest / Ticker: ARCT

Ticker: ARCT

08:06am, Wednesday, Oct 22, 2025

Arcturus Therapeutics Shares Dive on Disappointing Cystic Fibrosis Trial Results

Arcturus Therapeutics (NASDAQ: ARCT) stock tumbles sharply after cystic fibrosis trial delivers underwhelming data, raising questions about its pipeline prospects and investor confidence.